Tuyen Ong

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Craig M. McDonald, Craig Campbell, Ricardo Erazo Torricelli et al. · The Lancet · 2017 · 455 citations · Full text

Medicine, Molecular Medicine, Neurology +9

A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study

Robert N. Weinreb, Tuyen Ong, Baldo Scassellati Sforzolini et al. · British Journal of Ophthalmology · 2014 · 171 citations · Full text

Medicine, Ophthalmology, Pharmacology +17

Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years

Karla Zadnik, Erica Schulman, Ian Flitcroft et al. · JAMA Ophthalmology · 2023 · 124 citations · Full text

Health Professions, Ophthalmology, Pharmacotherapy +17

Latanoprost in port wine stain related paediatric glaucoma

Tuyen Ong · British Journal of Ophthalmology · 2003 · 48 citations · Full text

Medicine, Ophthalmology, Surgery +15

Prolonged Exposure to Loteprednol Etabonate in Human Tear Fluid and Rabbit Ocular Tissues Following Topical Ocular Administration of Lotemax Gel, 0.5%

Shellise Glogowski, Ezra R. Lowe, R. Siou-Mermet et al. · Journal of Ocular Pharmacology and Therapeutics · 2013 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17